Showing results (171-180 of 275) with videos related to

Sort By:
Pageof 28
Science (New York, N.Y.)|November 2, 2019
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogensMichael J Mina, Tomasz Kula, Yumei Leng, et al.
Scientific Reports|August 19, 2017
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In VivoArwen F Altenburg, Carolien E van de Sandt, Bobby W S Li, et al.
NPJ Vaccines|June 29, 2026
Proxy immunization enabling yellow fever vaccination after thymectomyEmilie C Rijnink, Muriel Aguilar-Bretones, Rory D de Vries, et al.
Emerging Microbes & Infections|July 5, 2022
Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamstersMelanie Rissmann, Danny Noack, Debby van Riel, et al.
Journal of Clinical Immunology|May 25, 2023
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of ImmunityLeanne P M van Leeuwen, Marloes Grobben, Corine H GeurtsvanKessel, et al.
Physical Review Letters|March 24, 2020
Observation of Radar Echoes from High-Energy Particle CascadesS Prohira, K D de Vries, P Allison, et al.
JCI Insight|October 6, 2020
Alveolar barrier disruption in varicella pneumonia is associated with neutrophil extracellular trap formationWerner Jd Ouwendijk, Henk-Jan van den Ham, Mark W Delany, et al.
NPJ Vaccines|May 28, 2024
SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunityMuriel Aguilar-Bretones, Yvette den Hartog, Laura L A van Dijk, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 20, 2024
Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023Leanne Pm van Leeuwen, Marc C Shamier, Babs E Verstrepen, et al.
Pageof 28